Page 1437 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1437

4       References


                        as compared with those produced by an increase in potassium.     136. Allon M, Copkney C. Albuterol and insulin for treat-
                        Circ Res. 1953;1(3):206-218.                            ment  of  hyperkalemia  in  hemodialysis  patients.  Kidney Int.
                      117. Braun HA, et al. The influence of hypocalcemia induced by   1990;38(5):869-872.
                        sodium ethylenediamine tetraacetate on the toxicity of potas-    137. Schwarz KC, et al. Severe acidosis and hyperpotassemia treated
                        sium; an experimental study.  J Lab Clin Med. 1955;46(4):   with  sodium bicarbonate infusion.  Circulation. 1959;19(2):
                        544-548.                                                215-220.
                      118. Surawicz B, Chlebus H, Mazzoleni A. Hemodynamic and elec-    138. Burnell JM, VM, Uyeno BT, Scribner BH. The effect in humans
                        trocardiographic effects of hyperpotassemia. Differences in   of extracellular pH change on the relationship between serum
                        response to slow and rapid increases in concentration of plasma   potassium concentration and intracellular potassium.  J Clin
                        K. Am Heart J. 1967;73(5):647-664.                      Invest. 1956(35):935.
                      119. Surawicz B, LE. The electrocardiogram in  hyper-potassemia.     139. Blumberg AL, et al. Selectivity of metoclopramide for endo-
                        Heart Bull. 1961(10).                                   crine  versus renal effects of  dopamine in normal humans.
                      120. Evers  S,  et  al.  Secondary  hyperkalaemic  paralysis.  J Neurol   J Cardiovasc Pharmacol. 1988;11(2):181-186.
                        Neurosurg Psychiatry. 1998;64(2):249-252.            140. Mahajan SK, Mangla M, Kishore K. Comparison of aminophyl-
                      121. Howard MR, et al. Artefactual serum hyperkalaemia and   line and insulin-dextrose infusions in acute therapy of hyper-
                        hypercalcaemia in essential thrombocythaemia.  J Clin Pathol.   kalemia in end-stage renal disease patients. J Assoc Physicians
                        2000;53(2):105-109.                                     India. 2001;49:1082-1085.
                      122. Don BR, et al. Pseudohyperkalemia caused  by fist clenching     141. Blumberg A. et al. Effect of various therapeutic approaches
                        during phlebotomy. N Engl J Med. 1990;322(18):1290-1292.  on plasma potassium and major regulating factors in terminal
                                                                                renal failure. Am J Med. 1988;85(4):507-512.
                      123. Bisogno JL, Langley A, Von Dreele MM. Effect of calcium to
                        reverse the electrocardiographic effects of hyperkalemia in the     142. Jackson MA, Lodwick R, Hutchinson SG. Hyperkalaemic car-
                        isolated rat heart: a prospective, dose-response study. Crit Care   diac  arrest  successfully  treated  with  peritoneal  dialysis.  BMJ.
                        Med. 1994;22(4):697-704.                                1996. 312(7041):1289-1290.
                      124. Nugent M, Tinker JH, Moyer TP. Verapamil worsens rate of     143. Schummer WJ, Schummer C. Hyperkalemic cardiac arrest: the
                        development and hemodynamic effects of acute hyperkalemia   method chosen depends on the local circumstances. Crit Care
                        in halothane-anesthetized dogs: effects of calcium therapy.   Med. 2002;30(7):1674-1675.
                        Anesthesiology. 1984;60(5):435-439.                  144. Evans BM, et al. Ion-exchange resins in the treatment of anuria.
                      125. Emmett M. Non-dialytic treatment of acute hyperkalemia in the   Lancet. 1953;265(6790):791-795.
                        dialysis patient. Semin Dial. 2000;13(5):279-280.    145. Gruy-Kapral  C, et al. Effect of single  dose resin- cathartic
                      126. Bower JO, MH. The additive effect of calcium and digitalis in   therapy on serum  potassium  concentration in patients
                        the dialysis patient. JAMA. 1936(106).                  with end-stage renal disease.  J  Am  Soc  Nephrol. 1998;9(10):
                                                                                1924-1930.
                      127. Fenton F, Smally AJ, Laut J. Hyperkalemia and digoxin toxicity
                        in a patient with kidney failure. Ann Emerg Med. 1996;28(4):     146. Wootton FT, et al. Colonic necrosis with Kayexalate-
                        440-441.                                                sorbitol enemas after renal transplantation.  Ann Intern Med.
                                                                                1989;111(11):947-949.
                      128. Van Deusen SK, Birkhahn RH, Gaeta TJ. Treatment of hyperka-
                        lemia in a patient with unrecognized digitalis toxicity. J Toxicol     147. Rashid A, Hamilton SR. Necrosis of the gastrointestinal tract
                        Clin Toxicol. 2003;41(4):373-376.                       in uremic patients as a result of sodium polystyrene sulfonate
                                                                                (Kayexalate)  in  sorbitol:  an  underrecognized  condition.  Am J
                      129. Levine  M, Nikkanen  H,  Pallin  DJ.  The  effects  of  intrave-
                        nous calcium in patients with digoxin toxicity.  J Emerg Med.   Surg Pathol. 1997;21(1):60-69.
                        2011;40(1):41-46.                                    148. Gerstman BB, Kirkman R, Platt R. Intestinal necrosis associated
                                                                                with postoperative orally administered sodium polystyrene
                      130. Allon M, Shanklin N. Effect of bicarbonate administration on
                        plasma potassium in dialysis patients: interactions with insulin   sulfonate in sorbitol. Am J Kidney Dis. 1992;20(2):159-161.
                        and albuterol. Am J Kidney Dis. 1996;28(4):508-514.    149. Ahmed J, Weisberg LS. Hyperkalemia in dialysis patients. Semin
                                                                                Dial. 2001;14(5):348-356.
                      131. Mandelberg A, et al. Salbutamol metered-dose inhaler
                        with spacer for hyperkalemia: how fast? How safe? Chest.     150. Redaelli B, et al. Effect of a new model of hemodialysis potas-
                        1999;115(3):617-622.                                    sium removal on the control of ventricular arrhythmias. Kidney
                                                                                Int. 1996;50(2):609-617.
                      132. Montoliu J, et al. Treatment of hyperkalaemia in renal failure
                        with salbutamol inhalation. J Intern Med. 1990;228(1):35-37.    151. Lin JL, Huang CC. Successful initiation of hemodialysis during
                                                                                cardiopulmonary resuscitation due to lethal hyperkalemia. Crit
                      133. Montoliu J, Lens XM, Revert L. Potassium-lowering effect of
                        albuterol for hyperkalemia in renal failure.  Arch Intern Med.   Care Med. 1990;18(3):342-343.
                        1987;147(4):713-717.                                 152. Torrecilla C, de la Serna JL. Hyperkalemic cardiac arrest, pro-
                                                                                longed heart massage and simultaneous hemodialysis. Intensive
                      134. Du Plooy WJ, et al. The dose-related hyper-and-hypokalaemic
                        effects of salbutamol and its  arrhythmogenic potential.  Br J   Care Med. 1989;15(5):325-326.
                        Pharmacol. 1994;111(1):73-76.                        153. Quick G, Bastani B. Prolonged asystolic hyperkalemic car-
                      135. Ngugi NN, McLigeyo SO, Kayima JK. Treatment of hyperkalae-  diac arrest with no neurologic sequelae.  Ann Emerg Med.
                        mia by altering the transcellular gradient in patients with renal   1994;24(2):305-311.
                        failure: effect of various therapeutic approaches. East Afr Med J.     154. Kass G, Orrenius S. Calcium signaling and cytotoxicity. Environ
                        1997;74(8):503-509.                                     Health Perspect. 1999;107(suppl 1):25-35.








              Section08-O-Ref.indd   4                                                                                   12/10/2014   6:08:09 PM
   1432   1433   1434   1435   1436   1437   1438   1439   1440   1441   1442